JAMES R MCNAB
CIK 1190126 · last filed 2022-01-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$411.0K
Companies
2
Total Filings
37
Lifetime Open-Market Net
-$3.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TITAN PHARMACEUTICALS INC (TTNP) Delisted | Director | 52,690 | $4.61 | $242.9K | $242.3K | 9 | 2022-01-28 |
| CRIS | Director | 975,964 | $0.42 | $411.0K | -$3.29M | 27 | 2017-05-05 |
Recent Filings · Page 4 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-03-03 | CRIS | Gift (G) | −25,000 | $0 | EDGAR |
| 2009-02-06 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2008-08-08 | CRIS | Buy (P) | +50,000 | $78.2K | EDGAR |
| 2008-08-08 | CRIS | Buy (P) | −50,000 | -$78.2K | EDGAR |
| 2008-06-10 | CRIS | Buy (P) | −50,000 | -$71.2K | EDGAR |
| 2008-01-28 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2007-06-08 | CRIS | Grant (A) | +10,000 | $100 | EDGAR |
Showing 31–37 of 37
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.